Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001296
Filing Date
2025-05-15
Accepted
2025-05-15 06:01:35
Documents
89
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q derm-20250331x10q.htm   iXBRL 10-Q 1338083
2 EX-10.1 derm-20250331xex10d1.htm EX-10.1 101646
3 EX-10.2 derm-20250331xex10d2.htm EX-10.2 88756
4 EX-31.1 derm-20250331xex31d1.htm EX-31.1 13091
5 EX-31.2 derm-20250331xex31d2.htm EX-31.2 12883
6 EX-32.1 derm-20250331xex32d1.htm EX-32.1 6425
7 EX-32.2 derm-20250331xex32d2.htm EX-32.2 6329
  Complete submission text file 0001410578-25-001296.txt   7166185

Data Files

Seq Description Document Type Size
8 EX-101.SCH derm-20250331.xsd EX-101.SCH 61266
9 EX-101.CAL derm-20250331_cal.xml EX-101.CAL 66884
10 EX-101.DEF derm-20250331_def.xml EX-101.DEF 224783
11 EX-101.LAB derm-20250331_lab.xml EX-101.LAB 506749
12 EX-101.PRE derm-20250331_pre.xml EX-101.PRE 368601
92 EXTRACTED XBRL INSTANCE DOCUMENT derm-20250331x10q_htm.xml XML 1083096
Mailing Address 9237 E VIA DE VENTURA BLVD., SUITE 105 SCOTTSDALE AZ 85258
Business Address 9237 E VIA DE VENTURA BLVD., SUITE 105 SCOTTSDALE AZ 85258 480-434-6670
Journey Medical Corp (Filer) CIK: 0001867066 (see all company filings)

EIN.: 471879539 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41063 | Film No.: 25948333
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)